Literature DB >> 3163893

Clostridium difficile colitis following antiviral therapy in the acquired immunodeficiency syndrome.

J Colarian1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3163893     DOI: 10.1016/0002-9343(88)90316-6

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  9 in total

Review 1.  Drug-induced Clostridium difficile-associated disease.

Authors:  M L Job; N F Jacobs
Journal:  Drug Saf       Date:  1997-07       Impact factor: 5.606

2.  Chemotherapy patients with C. difficile colitis have outcomes similar to immunocompetent C. difficile patients.

Authors:  David B Stewart; Emmanuel Yacoub; Junjia Zhu
Journal:  J Gastrointest Surg       Date:  2012-06-13       Impact factor: 3.452

Review 3.  Zidovudine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  H D Langtry; D M Campoli-Richards
Journal:  Drugs       Date:  1989-04       Impact factor: 9.546

4.  Intravenous teicoplanin does not prevent Clostridium difficile associated diarrhea.

Authors:  C Wenisch; E Etzersdorfer; S Breyer; W Graninger
Journal:  Clin Investig       Date:  1994-11

Review 5.  Clostridium difficile: clinical disease and diagnosis.

Authors:  F C Knoop; M Owens; I C Crocker
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

6.  Pneumatosis intestinalis in a child with AIDS and pseudomembranous colitis.

Authors:  E M Burton; M G Mercado-Deane; K Patel
Journal:  Pediatr Radiol       Date:  1994

7.  Clostridium difficile colitis associated with valaciclovir.

Authors:  Susana De Andrés; Daniel Ferreiro; Maribel Ibánez; Angel Ballesteros; Benito García; Jose Luis Agud
Journal:  Pharm World Sci       Date:  2004-02

Review 8.  Diagnosis and treatment of colonic disease in AIDS.

Authors:  K E Mönkemüller; C M Wilcox
Journal:  Gastrointest Endosc Clin N Am       Date:  1998-10

9.  Colonization with Clostridium difficile in Children with Cancer.

Authors:  Shahnaz Armin; Shahin Shamsian; Hojatollah Drakhshanfar
Journal:  Iran J Pediatr       Date:  2013-08       Impact factor: 0.364

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.